Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion
Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion
Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) announced Tuesday that it has received final acceptance from the TSX Venture Exchange for its previously announced acquisition of a Canadian licensed producer of cannabis, AgMedica Bioscience Inc.
Decibel大麻股公司（TSXV:DB）（OTCQB:DBCCF）於週二宣佈已獲得交易所對其此前宣佈的收購一家加拿大持牌大麻生產商AgMedica Bioscience Inc.的最終接受。
The acquisition, arranged through an agreement with Callisto Capital Corp. on October 28, 2024, was made in exchange for a $6.3 million unsecured convertible debenture. As a result of receiving the acceptance, Decibel has completed the conversion of the convertible debenture, pursuant to which it has issued 114.55 million common shares to Callisto.
該收購是通過與Callisto Capital corp.於2024年10月28日達成的協議進行的，交換條件爲630萬無擔保可轉換債券。由於收到接受，Decibel已完成可轉換債券的轉換，依據此，它向Callisto發行了11455萬普通分享。
The conversion of the convertible debenture was conditional upon receipt of final TSXV acceptance for the acquisition of AgMedica pursuant to Exchange Policy 5.3. This policy would have required approval from disinterested shareholders if Callisto became a major controller of the company. However, because the company has finished its recent private funding, Callisto will not control the company after the bond is converted. Therefore, approval from disinterested shareholders is not needed for the conversion.
可轉換債券的轉換以獲得交易所政策5.3下對AgMedica收購的最終TSXV接受爲條件。該政策要求如果Callisto成爲公司的主要人形機器人-電機控制器，則需要不相關股東的批准。然而，由於公司完成了最近的定向增發，Callisto在債券轉換後將不會控制公司。因此，轉換不需要不相關股東的批准。
Read Also: Cannabis Giant High Tide Taps Into $113 Billion Global E-Commerce Market With New Product Categories
另見：大麻巨頭High Tide新產品類別進軍1130億全球電子商務市場
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
訂閱本新聞快訊，每天免費獲取Benzinga獨家分析和大麻股行業及市場的最新資訊。如果您對業務認真，不容錯過。在這裏訂閱我們的新聞簡報。
On Nov. 25, the Calgary, Alberta-based cannabis company confirmed completion of the second and final closing of non-brokered private placement of its common shares at $0.06 per share. At the second closing of the offering, it issued 19.65 million shares for gross proceeds of roughly $1.18 million.
11月25日，總部位於卡爾加里，阿爾伯塔省的大麻公司確認完成其以每分享$0.06的普通分享的非中介定向增發的第二次和最終閉幕。在第二次閉幕中，它發行了1965萬分享，粗略收益約爲118萬。
Previously, Decibel projected that AgMedica could contribute $30 million of net revenue and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro-forma basis.
之前，Decibel預計AgMedica在2025年可貢獻3000萬的營業收入和400萬的EBITDA，預測2025年總營業收入爲13000萬，調整後EBITDA爲2500萬，基於形式預測。
The transaction is expected to materially expand Decibel's international footprint with EU GMP certification that enables export of flower and a variety of extract products, with proven sales to seven different countries including Australia, Denmark, Germany, Israel, Norway, Spain and the United Kingdom.
該交易預計將顯著擴大Decibel的國際足跡，符合歐盟GMP認證，可導出花和多種提取產品，已證明向包括澳洲、丹麥、德國、以色列、挪威、西班牙和英國在內的七個不同國家銷售。
Price Action
股價變動
Decibel shares closed Monday's market session 6.62% higher at $0.0499 per share.
Decibel的股價在週一的市場交易中上漲了6.62%，每股價格爲$0.0499。
- Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%
- Health Canada Cuts $14.6M From Cannabis Program Amid Federal Austerity
- 加拿大大麻股公司Decibel報告第三季度營業收入同比下降12%，但毛利率提升至53%。
- 加拿大衛生部在聯邦緊縮政策中削減了1460萬加元的大麻股項目。
Photo: Courtesy of pashabo via Shutterstock
圖片來源：pashabo via shutterstock
譯文內容由第三人軟體翻譯。
